معرفی
Dr. Shabah Mohammad Shadli is a researcher at Charles Sturt University, focusing on psychiatric neuroscience and psychopharmacology. Their work centers on developing biomarkers for anxiety and depression, particularly examining frontal theta oscillations and ketamine-based treatments for treatment-resistant disorders.
- Research Themes: Anxiety disorder biomarkers, ketamine therapy, frontal lobe function, treatment resistance mechanisms
- Key Collaborations: International partnerships in neuropsychopharmacology
Recent publications highlight their investigation into goal conflict processing and kynurenic acid pathway interactions. They received the Towards developing an anxiety process biomarker award from Charles Sturt University in 2024.
- Ketamine Research: 2025 studies on OCD, depression/PTSD comorbidities, and longitudinal effects
- Biomarker Development: 2024-2025 work validating EEG signatures for anxiety subtypes
۰مقاله منتشرشده
